全球急性肺损伤治疗市场研究报告 - 行业分析、规模、份额、增长、趋势及2023至2030年预测
市场调查报告书
商品编码
1305238

全球急性肺损伤治疗市场研究报告 - 行业分析、规模、份额、增长、趋势及2023至2030年预测

Global Acute Lung Injury Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: | 出版商: Value Market Research | 英文 120 Pages | 商品交期: 最快1-2个工作天内

价格

预计到2030年,全球急性肺损伤治疗市场需求将从2022年的62.2亿美元增至92.7亿美元,2022-2030年复合年增长率为5.12%。

急性肺损伤(ALI)是指肺部严重发炎,导致肺部积液和气体交换受损。急性肺损伤是一种需要立即治疗的医疗紧急情况。ALI的治疗旨在控制病情的根本原因,并提供支持性护理以改善肺功能和氧合。ALI的治疗非常复杂,根据病情的严重程度和潜在病因,治疗方法可能会有所不同。对ALI的密切监测和管理对于改善预后和预防并发症至关重要。

市场动态:

ALI发病率的上升,尤其是重症患者的发病率上升,是ALI治疗市场的主要驱动力。ALI发病率上升的主要原因是人口老龄化、慢性病患病率上升以及住院率升高。技术进步大大改善了ALI的诊断和治疗。抗炎药物和免疫调节剂等新治疗药物的开发使ALI的治疗更有效、更有针对性。世界各国政府和监管机构正投入巨资开发ALI的新疗法。医护人员越来越意识到ALI的潜在风险和后果,从而更早进行诊断和治疗。这种意识推动了对ALI治疗的需求。对无创通气技术,如持续气道正压和双水平气道正压的需求正在增加。与可能导致感染和肺损伤等并发症的有创机械通气相比,这些技术更受青睐。个性化医疗日益受到重视:个性化医疗在ALI治疗市场越来越受欢迎。这种方法是根据患者的基因构成、病史和其他因素为其量身定制治疗方案。个性化医疗有望为ALI带来更有效、更有针对性的治疗。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰了解行业结构,评估全球竞争吸引力。此外,这些工具还对全球急性肺损伤治疗市场的各个细分市场进行了全面评估。急性肺损伤治疗行业的增长和趋势为本研究提供了整体方法。

市场细分:

急性肺损伤治疗市场报告的这一部分提供了国家和地区层面细分市场的详细数据,从而帮助战略家确定各自产品或服务的目标人群以及即将到来的机会。

按疗法分类

  • 机械通气
  • 药物治疗
  • 液体管理
  • 其他

按终端用户

  • 医院
  • 专科中心
  • 其他

区域分析

本部分涵盖了区域前景,突出了北美、欧洲、亚太、拉美以及中东和非洲地区急性肺损伤治疗市场的当前和未来需求。此外,报告还重点介绍了所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的综合概况以及全球竞争格局的深入分析。急性肺损伤治疗市场的主要参与者包括梅奥诊所、约翰霍普金斯医院、克利夫兰诊所、大奥蒙德街医院、阿波罗医院、东京医科大学附属医院、查尔斯王子医院、Helios医院、Aster医院等。本节包括竞争格局的整体视图,其中包括各种战略发展,如关键并购、未来能力、合作伙伴关系、财务概况、合作、新产品开发、新产品上市和其他发展。

目 录

第一章:前言

  • 报告描述
    • 报告目标
    • 目标受众
    • 独特销售主张(USP)和产品
  • 研究范围
  • 研究方法
    • 市场调研流程
    • 市场调研方法

第二章:执行摘要

  • 市场亮点
  • 全球市场概况

第三章:急性肺损伤治疗-行业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 行业趋势
  • 波特五力分析
  • 市场吸引力分析
    • 按疗法分类的市场吸引力分析
    • 按终端用户的市场吸引力分析
    • 市场吸引力分析:按地区

第四章:价值链分析

  • 价值链分析
  • 原材料分析
    • 原材料清单
    • 原材料制造商列表
    • 主要原材料价格走势
  • 潜在买家名单
  • 营销渠道
    • 直接营销
    • 间接营销
    • 营销渠道发展趋势

第五章:covid-19爆发的影响分析

第六章:全球急性肺损伤治疗市场分析:按疗法分类

  • 按疗法概述
  • 历史和预测数据
  • 按疗法分析
  • 机械通气
  • 药物治疗
  • 输液管理
  • 其他治疗

第七章 :全球急性肺损伤治疗市场分析:按最终用户分类

  • 终端用户概述
  • 历史和预测数据
  • 按最终用户分析
  • 医院
  • 专科中心
  • 其他

第8章:全球急性肺损伤治疗市场分析:按地区划分

  • 地区前景
  • 产品介绍
  • 北美销售分析
    • 概述、历史和预测销售分析
    • 北美地区销售分析
    • 北美地区各国销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概述、历史和预测销售分析
    • 欧洲销售分析
    • 欧洲各国销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 意大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概述、历史和预测销售分析
    • 亚太地区各细分市场销售分析
    • 亚太地区各国销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳大利亚销售分析
    • 亚太其他地区销售分析
  • 拉丁美洲销售分析
    • 概述、历史和预测销售分析
    • 拉丁美洲各细分市场销售分析
    • 拉丁美洲各国销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概述、历史和预测销售分析
    • 中东及非洲地区销售分析
    • 中东和非洲国家销售分析
    • 沙特阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东和非洲其他地区销售分析

第九章 : 急性肺损伤治疗企业竞争格局

  • 急性肺损伤治疗市场竞争格局
  • 伙伴关系/合作/协议
  • 合并与收购
  • 新产品上市
  • 其他发展

第10章 : 公司概况

  • 顶级公司市场份额分析
  • 市场集中度
  • Mayo Clinic
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Johns Hopkins Hospital
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Cleveland Clinic
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Great Ormond Street Hospital
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Apollo Hospitals
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Tokyo Medical University Hospital
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • The Prince Charles Hospital
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Helios Hospital
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Aster Hospitals
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Other
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展

注-在公司概况中,财务细节和近期发展视情况而定,如果是私营公司则可能不包括在内。

Product Code: VMR112110671

The global demand for Acute Lung Injury Treatment Market is presumed to reach the market size of nearly USD 9.27 BN by 2030 from USD 6.22 BN in 2022 with a CAGR of 5.12% under the study period 2022 - 2030.

Acute Lung Injury (ALI) is a condition in which the lungs become severely inflamed, leading to fluid accumulation in the lungs and impaired gas exchange. ALI is a medical emergency that requires immediate treatment. The treatment of ALI is aimed at managing the underlying cause of the condition and providing supportive care to improve lung function and oxygenation. The treatment of ALI is complex, and the approach may vary depending on the severity of the condition and the underlying cause. Close monitoring and management of ALI are crucial to improve outcomes and prevent complications.

Market Dynamics:

The rising prevalence of ALI, especially among critically ill patients, is a major driver of the ALI treatment market. The increasing incidence of ALI is primarily due to the aging population, increased prevalence of chronic diseases, and higher rates of hospitalization. Technological advancements have significantly improved the diagnosis and treatment of ALI. The new therapeutic agents development, such as anti-inflammatory drugs and immunomodulatory agents, has led to more effective and targeted treatments for ALI. Governments and regulatory bodies worldwide are investing heavily in the development of new treatments for ALI. This funding is driving research and development efforts in the field, leading to the development of new and innovative therapies.Healthcare professionals are becoming more aware of the potential risks and consequences of ALI, leading to earlier diagnosis and treatment. This awareness is driving the demand for ALI treatment. The demand for non-invasive ventilation techniques, such as continuous positive and bi-level positive airway pressure is increasing. These techniques are preferred over invasive mechanical ventilation, which can cause complications such as infections and lung injury. Growing focus on personalized medicine: Personalized medicine is gaining popularity in the ALI treatment market. This approach involves tailoring treatments to the individual patient, taking into account their genetic makeup, medical history, and other factors. Personalized medicine is expected to lead to more effective and targeted treatments for ALI.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of acute lung injury treatment. The growth and trends of acute lung injury treatment industry provide a holistic approach to this study.

Market Segmentation:

This section of the acute lung injury treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Therapy

  • Mechanical Ventilation
  • Pharmacotherapy
  • Fluid Management
  • Others

By End-User

  • Hospitals
  • Specialty Centers
  • Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Acute Lung Injury Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the acute lung injury treatment market include Mayo Clinic, Johns Hopkins Hospital, Cleveland Clinic, Great Ormond Street Hospital, Apollo Hospitals, Tokyo Medical University Hospital, The Prince Charles Hospital, Helios Hospital, Aster Hospitals, Other. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . ACUTE LUNG INJURY TREATMENT - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Therapy
    • 3.7.2 Market Attractiveness Analysis By End-User
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL ACUTE LUNG INJURY TREATMENT MARKET ANALYSIS BY THERAPY

  • 6.1 Overview by Therapy
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Therapy
  • 6.4 Mechanical Ventilation Historic and Forecast Sales by Regions
  • 6.5 Pharmacotherapy Historic and Forecast Sales by Regions
  • 6.6 Fluid Management Historic and Forecast Sales by Regions
  • 6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL ACUTE LUNG INJURY TREATMENT MARKET ANALYSIS BY END-USER

  • 7.1 Overview by End-User
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by End-User
  • 7.4 Hospitals Historic and Forecast Sales by Regions
  • 7.5 Specialty Centers Historic and Forecast Sales by Regions
  • 7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL ACUTE LUNG INJURY TREATMENT MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1. Overview, Historic and Forecast Sales Analysis
    • 8.3.2. North America By Segment Sales Analysis
    • 8.3.3. North America By Country Sales Analysis
    • 8.3.4. United State Sales Analysis
    • 8.3.5. Canada Sales Analysis
    • 8.3.6. Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1. Overview, Historic and Forecast Sales Analysis
    • 8.4.2. Europe by Segment Sales Analysis
    • 8.4.3. Europe by Country Sales Analysis
    • 8.4.4. United Kingdom Sales Analysis
    • 8.4.5. France Sales Analysis
    • 8.4.6. Germany Sales Analysis
    • 8.4.7. Italy Sales Analysis
    • 8.4.8. Russia Sales Analysis
    • 8.4.9. Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1. Overview, Historic and Forecast Sales Analysis
    • 8.5.2. Asia Pacific by Segment Sales Analysis
    • 8.5.3. Asia Pacific by Country Sales Analysis
    • 8.5.4. China Sales Analysis
    • 8.5.5. India Sales Analysis
    • 8.5.6. Japan Sales Analysis
    • 8.5.7. South Korea Sales Analysis
    • 8.5.8. Australia Sales Analysis
    • 8.5.9. Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1. Overview, Historic and Forecast Sales Analysis
    • 8.6.2. Latin America by Segment Sales Analysis
    • 8.6.3. Latin America by Country Sales Analysis
    • 8.6.4. Brazil Sales Analysis
    • 8.6.5. Argentina Sales Analysis
    • 8.6.6. Peru Sales Analysis
    • 8.6.7. Chile Sales Analysis
    • 8.6.8. Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1. Overview, Historic and Forecast Sales Analysis
    • 8.7.2. Middle East & Africa by Segment Sales Analysis
    • 8.7.3. Middle East & Africa by Country Sales Analysis
    • 8.7.4. Saudi Arabia Sales Analysis
    • 8.7.5. UAE Sales Analysis
    • 8.7.6. Israel Sales Analysis
    • 8.7.7. South Africa Sales Analysis
    • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE ACUTE LUNG INJURY TREATMENT COMPANIES

  • 9.1. Acute Lung Injury Treatment Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF ACUTE LUNG INJURY TREATMENT INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Mayo Clinic
    • 10.3.1. Company Overview
    • 10.3.2. Company Revenue
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. Johns Hopkins Hospital
    • 10.4.1. Company Overview
    • 10.4.2. Company Revenue
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Cleveland Clinic
    • 10.5.1. Company Overview
    • 10.5.2. Company Revenue
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Great Ormond Street Hospital
    • 10.6.1. Company Overview
    • 10.6.2. Company Revenue
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. Apollo Hospitals
    • 10.7.1. Company Overview
    • 10.7.2. Company Revenue
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. Tokyo Medical University Hospital
    • 10.8.1. Company Overview
    • 10.8.2. Company Revenue
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. The Prince Charles Hospital
    • 10.9.1. Company Overview
    • 10.9.2. Company Revenue
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. Helios Hospital
    • 10.10.1. Company Overview
    • 10.10.2. Company Revenue
    • 10.10.3. Products
    • 10.10.4. Recent Developments
  • 10.11. Aster Hospitals
    • 10.11.1. Company Overview
    • 10.11.2. Company Revenue
    • 10.11.3. Products
    • 10.11.4. Recent Developments
  • 10.12. Other
    • 10.12.1. Company Overview
    • 10.12.2. Company Revenue
    • 10.12.3. Products
    • 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Therapy (USD MN)
  • Mechanical Ventilation Market Sales by Geography (USD MN)
  • Pharmacotherapy Market Sales by Geography (USD MN)
  • Fluid Management Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis Market by End-User (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Specialty Centers Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Acute Lung Injury Treatment Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Acute Lung Injury Treatment Report
  • Market Research Process
  • Market Research Methodology
  • Global Acute Lung Injury Treatment Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Therapy
  • Market Attractiveness Analysis by End-User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Therapy (USD MN)
  • Mechanical Ventilation Market Sales by Geography (USD MN)
  • Pharmacotherapy Market Sales by Geography (USD MN)
  • Fluid Management Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by End-User (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Specialty Centers Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.